Stocks360

AVVAA World Health Care Products, Inc. (AVVH)

Stock analysis · OTC · Financial Services · Financial - Mortgages

Share: Facebook X WhatsApp SMS
$0.00

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$2.71M
PE (TTM)
-88.43
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.67
Day Range
$0.00 – $0.00
52-wk Range
$0.00 – $0.00
Avg Volume
N/A
Volume
108.61K

AVVAA World Health Care Products, Inc. (AVVH) is a publicly traded company in the Financial Services sector. Latest price: $0.00. Market cap $2.71M. Trailing PE -88.43. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $0.00 2026-10-28 · $0.00 (-15.15%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About AVVAA World Health Care Products, Inc.

AVVAA World Health Care Products, Inc. operates as a global biotechnology firm, specializing in natural and therapeutic personal care solutions. Its primary endeavor involves the development, manufacturing, and mass-market distribution of the over-the-counter Neuroskin product line. These treatments are formulated to address various skin irregularities and promote the natural clarity and texture of healthy skin, reaching consumers through conventional food and drug channels. Beyond its own brands, AVVAA also possesses distribution rights for a range of patented European skincare items. These scientifically-backed formulations target the symptoms of persistent dermatological conditions such as eczema, psoriasis, and acne. Diversifying its portfolio, the company extends its natural care offerings to animals, providing grooming treatments for a variety of pets including dogs, cats, and horses. Established in 1998 and headquartered in Richmond, Virginia, AVVAA has been a subsidiary of Gold Quest Capital, Inc. since June 23, 2021.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-88.43×
P/S (TTM)15.26×
P/B23.76×
P/FCF (TTM)3.19×
EV / EBITDA-350.77×
EV / Sales22.31×
Earnings Yield-1.13%
Free Cash Flow Yield31.33%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$3.96M
Revenue (TTM)$177.44K
Net Income (TTM)-$30.62K
Free Cash Flow (TTM)$867.66K
Net Debt$1.25M
Working Capital$196.60K
Gross Margin25.42%
Operating Margin-6.36%
Net Margin-17.26%
Return on Equity-24.22%
Return on Invested Capital-0.77%

Peers

Recent News

Related

Browse more tickers: sitemap